INSULIN DRUGS AND THEIR ASSOCIATION WITH ALZHEIMER'S DISEASE

Registration ID: IJNRD_192753

Published ID: IJNRD2304621

: Click Here to Get

Dr. Anjana Devi, MR. Ankush Kumar, MS .Anu Bhatia, MS. Sara Sharma

Insulin Analogues, Human Insulin, Insulin administration, and Hyperkalaemia.

The insulin formerly derived from animal sources such as bovine, porcine and bovine-porcine has been replaced by human insulin and its equivalents. Structurally modified synthetic versions of these are created. These come from a variety of sources, mainly human insulin analogs. The only difference between human insulin and similar substances is the duration of action. For example, in the US only similar insulin is used and commercially available bovine and porcine insulin is not. Absorption, potency, and duration of action will change as a result of these changes. Similar to the first phase of insulin release, these forms are observed to achieve rapid pharmacodynamics and pharmacokinetics (ADME). These analogs work by mimicking the typical physiology of insulin. These are also believed to aid in postprandial glycemic management. Physiological and anatomical impairments are the early diagnostic features of Alzheimer's disease. These are now understood to be a crucial part of the pathogenesis of Alzheimer's disease. The sensitizer offers comfort and support for ideas that have been established in animal models of amyloidosis, such as B. An abnormal production can lead to insulin resistance, which contributes to a variety of cognitive disorders. Brain injury stimulates the production of A and causes insulin resistance, which is then alleviated by the sensitizer. The focus of this review is on insulin medicine, molecular mechanisms, and all aspects of memory related to Alzheimer's disease.

Published Paper   E-Certificate

Dr. Anjana Devi, MR. Ankush Kumar, MS .Anu Bhatia, & MS. Sara Sharma (April-2023). INSULIN DRUGS AND THEIR ASSOCIATION WITH ALZHEIMER'S DISEASE. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(4), g155-g165. https://ijnrd.org/papers/IJNRD2304621.pdf

Volume 8 Issue 4, April-2023

Pages : g155-g165

Paper Reg. ID: IJNRD_192753

Published Paper Id: IJNRD2304621

Downloads: 000122000

Research Area: Pharmacy

Author Type: Indian Author

Country: Hamirpur/ Hamirpur, Himachal pradesh, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2304621.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2304621

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.

You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.

Call For Paper - Volume 10 | Issue 11 | November 2025

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.

For more details, refer to the official notice: UGC Public Notice

Submit Paper Online

Important Dates for Current issue

Paper Submission Open For: November 2025

Current Issue: Volume 10 | Issue 11 | November 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 30-Nov-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details

Approval, Licenses and Indexing: More Details